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Abstract
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a genetic disorder resulting in large kidney cysts and eventual
kidney failure. Mutations in either the PKD1 or PKD2/TRPP2 genes and their respective protein products, polycystin-1 (PC1)
and polycystin-2 (PC2) result in ADPKD. PC2 is known to function as a non-selective cation channel, but PC1’s function and
the function of PC1 cleavage products are not well understood. Here we identify an endogenous PC1 cleavage product,
P100, a 100 kDa fragment found in both wild type and epitope tagged PKD1 knock-in mice. Expression of full length human
PC1 (FL PC1) and the resulting P100 and C-Terminal Fragment (CTF) cleavage products in both MDCK and CHO cells
significantly reduces the store operated Ca
2+ entry (SOCE) resulting from thapsigargin induced store depletion. Exploration
into the roles of P100 and CTF in SOCE inhibition reveal that P100, when expressed in Xenopus laevis oocytes, directly
inhibits the SOCE currents but CTF does not, nor does P100 when containing the disease causing R4227X mutation.
Interestingly, we also found that in PC1 expressing MDCK cells, translocation of the ER Ca
2+ sensor protein STIM1 to the cell
periphery was significantly altered. In addition, P100 Co-immunoprecipitates with STIM1 but CTF does not. The expression
of P100 in CHO cells recapitulates the STIM1 translocation inhibition seen with FL PC1. These data describe a novel
polycystin-1 cleavage product, P100, which functions to reduce SOCE via direct inhibition of STIM1 translocation; a function
with consequences for ADPKD.
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Introduction
Ca
2+ homeostasis plays a vital role in the normal development
of tubules in the mammalian nephron [1,2]. Dysregulation of Ca
2+
homeostasis is characteristic in the cyst formation associated with
Autosomal Dominant Polycystic Kidney Disease (ADPKD)[3], but
how dysregulation leads to cyst production is not well understood.
ADPKD results from mutations in the polycystin genes PKD1 and
PKD2/TRPP2 and mutations in their respective polycystin
proteins, Polycystin 1 (PC1) and Polycystin 2 (PC2), both of which
have been implicated as significant regulators of intracellular Ca
2+
in renal tubules [4]. PC2 is a member of the transient receptor
potential (TRP) family of ion channels [3] and has been
demonstrated to be Ca
2+ permeant in cilia, plasma, and ER
membranes [3,5,6]. PC2 is known to regulate ER calcium
permeability [7] and modulate IP3R [8] to lower ER Ca
2+ stores.
PC1’s function in Ca
2+ homeostasis is far less clear.
Tubular cysts result from a dysfunction in either PC1 or PC2,
suggesting a common functional pathway. This idea is supported
by evidence that PC1 must bind PC2 in order for PC2 to function
as a Ca
2+ channel [6]. A PC1, PC2 complex may function as a
flow transducer on the primary cilium of epithelial cells [5],
wherein flow transduction may be necessary for proper tubule
alignment and formation [9]. However a second, less overt
relationship may exist between PC1 and PC2, one revolving
around a tight regulation of cytosolic and ER Ca
2+, where a
disruption of any Ca
2+ regulator can lead to cyst formation.
Normal PC2 expression and the resulting lower ER Ca
2+ levels
should increase Ca
2+ influx and lead to apoptosis and increased
cell proliferation [10], but does not. However, mutations or the
loss of PC1 results in increased proliferation and apoptosis [2],
suggesting that PC1 may be involved in regulating Ca
2+ influx.
PC1 may also play an important role in regulating cellular Ca
2+
responses to stimuli, as PC1 has been reported to alter ATP
activated intracellular Ca
2+ increases by influencing the rate of
Ca
2+ reuptake in the ER [11].
ER Ca
2+ store depletion is sensed by proteins of the stromal
interaction molecule (STIM) family, specifically, STIM1 [12].
STIM1 is found predominantly in the ER membrane, where an
EF hand region, located on its C-terminus within the ER lumen,
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2+ molecules [12]. When ER stores are depleted,
STIM1 re-localizes within the ER membrane to puncta opposite
the plasma membrane [12], allowing for STIM1 to physically
interact with Orai, a predicted subunit of store operated Ca
2+
channels (SOC) [13]. STIM1, therefore, is thought to act as the
ER Ca
2+ sensor that directly activates the SOC channels to
replenish ER Ca
2+ levels.
Deciphering the role PC1 plays in Ca
2+ homeostasis either at
the ER or plasma membranes is further complicated by the
cleavage of the PC1 protein and a lack of understanding about
PC1 cleavage product localization. The first cleavage occurs
constitutively and partially at the juxtamembrane GPS domain,
generating a stable N-terminal fragment (NTF), and a C-terminal
fragment (CTF) that coexist with uncleaved full-length PC1 [14–
16]; the function of both products remains unclear. The second
cleavage event previously described for PC1 results in a small C-
terminal tail (CTT) fragment [17] that translocates into the
nucleus, where it associates with b-catenin to disrupt canonical
Wnt signaling [18]. PC1 localization is also controversial.
Demonstrating PC1 activity on the cellular and cilia membranes
has been the focus of the majority of PC1 work [1–3], however,
there exists evidence that PC1 may also occur on the ER
membrane [19,20].
Here we describe a novel PC1 cleavage product, P100. We
show that PC1, through its P100 product, inhibits Ca
2+ influx at
the plasma membrane, and we provide evidence that PC1
interacts with STIM1, preventing its re-localization after store
depletion. Our data support the hypothesis that PC1 and P100
regulate store operated calcium entry by interfering with STIM1’s
ability to activate SOC channels on the plasma membrane.
Results
Analysis of polycystin-1 reveals novel endogenous
cleavage product, P100
Using a PC1 C-terminal tail directed antibody (anti-CC-
antibody, [16]) (Figure 1A), we detected by Western blot a novel
PC1 product of approximately 100 kDa, here termed P100, in the
embryo and postnatal mouse, in addition to the previously
reported uncleaved full-length (uFL) and C-terminal fragment
(CTF) (Figure 1Bi). We found that P100 is also expressed at
various developmental stages of postnatal kidneys at levels
commensurate to that of CTF: it deceased with the postnatal
age and became undetectable at P21 (Figure 1Bii, iii). We detected
P100 in the kidney of the Pkd1
v/v mice where PC1 cleavage at
GPS is disrupted and CTF is thus absent (Figure 1C). We
confirmed the authenticity of P100 with the HA-tagged PKD1
knock-in mice (Pkd1
HA/HA), which express fully functional PC1
tagged with a 3xHA epitope at the C-terminus [21], and with
5XMyc tagged knock-in mice (Figure S1). We detected P100 in
MEF derived from the Pkd1
HA/HA mouse by anti-HA after
immunoprecipitation or directly in total lysate (Figure 1D). We
found that P100 is expressed at different levels in the tissues of the
developing mouse and its relative level to CTF also appears to
differ among the tissues (Figure 1E).
We detected similar PC1 products in a MDCK cell line with
inducible Flag-tagged full-length PC1 expression under the control
of a tetracycline sensitive promoter (Figure 2A) and in CHO cells
(Figure 2C) after transient over-expression of full-length Flag-
tagged PC1. This result indicates that P100 is likely generated by
proteolytic cleavage at a site that is predicted within the third
intracellular loop (Figure 1A) based on the apparent molecular size
of P100 and therefore is the portion of PC1 that has sequence
similarity to PC2 [22]. The relative amounts of the two cleavage
products, CTF and P100 appeared to vary from blot to blot under
seemingly similar experimental conditions. We found that 24 hour
treatment of MDCK cells with 40nM thapsigargin appeared to
reduced the amount of the CTF but not P100 (Figure 2A) whereas
10 mM of ionomycin did not; a result consistent with the
hypothesis that ER Ca
2+, not general intracellular Ca
2+ levels,
differentially affects the two cleavage processes.
Next we began an investigation into the possible functions of the
PC1 cleavage products on Ca
2+ homeostasis. It had previously
been reported that PC1 inhibited ATP-induced capacitative
calcium entry by increasing the rate of Ca
2+ uptake to the ER,
therefore reducing the stimulus for extracellular Ca
2+ entry [11].
We found, however, that after depletion of the ER Ca
2+ with
thapsigargin in a zero Ca
2+ bath, the reintroduction of Ca
2+ in the
control cells led to an increase in intracellular Ca
2+ (Figure 2B) and
this increase was significantly larger than in MDCK cells
expressing PC1-flag (p,0.001). We confirmed the result in
heterogeneous CHO cell populations after transient transfection
with full length (FL) PC1-GFP (Figure 2D). Our results suggest
that PC1 may also mediate inhibition of the extracellular Ca
2+
entry when ER filling is prevented by thapsigargin and raises the
possibility that PC1 may modulate SOCE current(s) directly at the
cell surface. However, in both MDCK and CHO cells, PC1 was
cleaved into CTF and P100. Could the cleavage products
themselves be responsible for modulating the SOCE currents?
CTF expression does not inhibit the SOC current
Xenopus laevis oocytes have well characterized Ca
2+ activated Cl-
currents (CaCC) [23,24] and both voltage activated Ca
2+ channels
and store operated Ca
2+ currents [24,25]. We found that Xenopus
oocytes, when subjected to a pretreatment with a zero Ca
2+
solution containing thapsigargin, displayed large inward currents
with complex kinetics (Figure S2). These ‘‘check’’ shaped currents
were a combination of a fast transient, Niflumic Acid (NFA)
sensitive, Ca
2+ activated Cl- current; and a smaller but non
deactivating, La3+ sensitive, store operated Ca
2+ current (Figure
S2). We used these endogenous currents of Xenopus laevis oocytes as
an electrophysiological model to examine the role of the PC1
cleavage products in the regulation of SOCE currents. The Xenopus
model system combines electrophysiological rigor with a cell type
that does not express mammalian PC2, a protein shown to affect
PC1 cleavage and expression of PC1 cleavage products [26],
allowing a clear picture of any role PC1 cleavage products may
have in regulating SOCE. We began with the larger CTF product
(Figure 3A). Surprisingly, the expression of CTF in oocytes had no
effect on either the transient peak (p,0.49) nor steady state
currents (p,0.25) as compared to H2O injected controls
(Figure 3B and 3C). To confirm that the lack of SOCE inhibition
was not specific to Xenopus oocytes we expressed the CTF construct
in CHO cells. In CHO cells first treated with zero Ca
2+ ringers
and thapsigargin, the reintroduction of extracellular Ca
2+ resulted
in comparable increases in Ca
2+ influx in both the control and
CTF expressing cells (Figure S3). These results suggest the CTF is
not involved in inhibiting SOC entry. Interestingly, CTF is not
further cleaved in Xenopus oocytes or CHO cells into a P100 sized
product.
P100 expression inhibits SOC currents
Unlike CTF, the precise cleavage site for P100 is unknown so
we created several constructs that start within the third
intracellular loop. One of them, starting at V3645, produced a
P100-like protein, which co-migrates with the P100 derived from
the FL PC1 construct (Figure 2C and E) and can be considered a
reasonable approximation of the P100. This construct was used for
SOCE Regulation by PC1
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CTF, P100 when expressed in Xenopus oocytes, had a significant
effect on the endogenous currents. In oocytes expressing P100, the
check current was dramatically reduced as compared to H20
injected controls (Figure 4A). A comparison of current amplitudes
at the transient peak and the steady state revealed P100 expressing
Figure 1. Biochemical characterization of a novel endogenous polycystin-1 product, P100. (A) Pkd1 alleles and schematic diagram of
their corresponding polycystin-1 proteins. Pkd1
HA is a 3xHA-tagged Pkd1 knock-in allele that produces fully functional PC1 protein. The domains in
polycystin-1 are shown. Anti-CC is directed to the cytoplasmic C-terminal tail. The position of uncleaved full-length (uFL), the C-terminal (CTF) and the
P100 product is schematically shown. (B) Western blots for wild-type embryo (E18.5), lung (Bi), and kidney (Bii and iii) at different postnatal stagesa s
indicated using anti-CC antibodies after immunoprecipitation. Western blot shown in Bii (enclosed by dashed box) originally from Yu et al 2007;
 2007 by The National Academy of Sciences of the USA. The bands corresponding to uFL, CTF and P100 are indicated. * indicates a band of
unknown nature in the lung. (C) Western blot for postnatal kidneys from PKD1v/v mice. (D) Western blot from mouse embryonic fibroblasts (MEF)
isolated from Pkd1
HA/HA and wild-type 11.5 day old embryos using anti-HA antibody after immunoprecipitation or on the whole cell lysate. (E)
Western blot for homozygous Pkd1
HA/HA tissues at P20 using anti-HA antibody after immunoprecipitation. The lung of the wild-type littermate (+/+)
serves as a negative control.
doi:10.1371/journal.pone.0012305.g001
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PLoS ONE | www.plosone.org 3 August 2010 | Volume 5 | Issue 8 | e12305Figure 2. In vitro biochemical and functional characterization of polycystin-1 cleavage products. (A) Western blot of PC1-flag protein
using anti-CT antibody after immunoprecipitation with flag conjugated beads from MDCK cells with stably transfected, tetracycline inducible PC1
expression. PC1 expression reveals three distinct bands: FL PC1, CTF, and P100. Right two lanes: the effect of 24 hours exposure of PC1 expressing
cells to either 10 mM ionomycin or 40 nM thapsigargin (overnight). Blots representative of at least 3 experiments. (B) Fura 2-AM measurements of
intracellular Ca
2+ in either MDCK cells with (red; n=5 coverslip, 99 cells) or without (black; n=5 coverslips, 120 cells) tetracycline induced PC1-flag
expression. Recordings began after cells reached steady state in a zero Ca
2+,4mM thapsigargin ringers. The bath was then replaced with a 5 mM Ca
2+
bath solution to measure the store operated calcium entry. Maximum SOC amplitudes (Df/f) were compared (***p,0.001). (C) Western blot of PC1
and recombinant PC1 cleavage product constructs CTF and P100, in CHO cells. Protein was immunoprecipitated with flag conjugated beads then
probed with anti-CT antibodies. Blot representative of at least three experiments. (D) Fura 2-AM measurements in CHO cells transiently transfected
with GFP-PC1 (red; n=12 coverslips, 65 cells) or with empty plasmid (black; n=7 coverslips, 58 cells). Maximum SOC amplitudes (Df/f) were compared
(**p,0.01). (E) Cartoons of different PC1 constructs used in current study: Full length PC1 with either an N-terminus GFP or C-terminus flag tag; CTF
construct with C-terminus flag tag; and P100 construct with both N-terminus myc tags and a C-terminus flag tag.
doi:10.1371/journal.pone.0012305.g002
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(Figure 4B)(transient peak p,0.01; steady state p,0.01); suggest-
ing both the CaCC current as well as the SOC current are being
inhibited.
We next attempted to discern if P100 expression was affecting
the SOCE only (secondarily affecting the CaCC), or affecting both
the SOCE and the CaCC directly. Xenopus oocytes have well
described voltage activated Ca
2+ channels [23] which are
responsible for the large outward CaCC currents seen when the
cell is depolarized. The voltage gated Ca
2+ channels were not
activated during the negative pulse used to elicit the ‘‘check’’
currents, but were activated by positive pre-pulses, thereby
providing a secondary source of Ca
2+ for CaCC activation.
Three, two second, +60 mV pre-pulses were delivered repeatedly
to cells expressing P100, causing the induction of a check current
(Figure 4C) significantly larger than the P100 suppressed current
in the same oocytes prior to pre-pulse delivery. Interestingly, the
induced current in the P100 oocytes was indistinguishable from
the NFA sensitive Cl- current calculated in Figure S2. If compared
to currents from H2O injected controls, the transient peak
appeared similar, but the induced current dissipated, where as the
control reached a steady state. An examination of the current
amplitudes during the transient peak revealed the induced current
was no different than the control peak (P,0.823)(Figure 4D). In
contrast, the current amplitudes at the steady state revealed no
induction or increase (p,0.15), but all three were significantly
smaller than the control steady state current (p,0.001). These
results strongly suggest that the CaCC currents are not being
directly affected by the expression of P100, but are being inhibited
indirectly, via an inhibition of the SOC current that is necessary for
their activation at 2120 mV.
To gain insight into whether the SOC current inhibitory effect
of P100 may have physiological relevance, we used the mutant
P100 expression construct bearing the disease-causing R4227X
mutation and tested for the effect of the mutation on SOC current
inhibition. The resulting mutant protein, P100 R4227X, lacks the
C-terminal 76 amino acids containing the coiled-coil domain
required for interacting with PC2 [6]. Expression of P100 R4227X
in Xenopus oocytes did not significantly reduce the transient peak
(p,0.50) or steady state currents (p,0.44)(Figure 4E and F). The
importance of the missing tail region from the P100 R4227X
mutant was confirmed by expression of an artificial PC1 product,
AESW, containing only the final transmembrane domain and the
C-terminal tail in Xenopus oocytes. AESW expressing oocytes
displayed an inhibited transient peak (p,0.01) and steady state
amplitudes (p,0.01) as compared to controls. Similarly, AESW
transient over expression inhibited extracellular Ca
2+ entry in
thapsigargin treated CHO cells (Figure S3). These results indicate
that the C-terminal sequence is required for the SOC inhibition
and suggests that this activity of P100 plays a critical role for the
physiological function of PC1.
PC1 interferes with STIM1 puncta formation after ER Ca
2+
depletion
We hypothesized that PC1, through the actions of its P100
product, may exert its inhibitory effect on SOCE by interfering
with STIM1 in the ER, retarding STIM1’s ability to transduce a
Ca2+ depletion signal to the SOCE channels of the plasma
membrane. Functionally, we sought to address this by measuring
the amount of STIM1 translocation to the periphery with or
without the expression of PC1. We chose to use a MDCK cell line
stably expressing mouse PC1, which we compared to empty vector
control cells. The MDCK (with or without mPC1) cells were
transfected with a YFP-STIM1 construct and photographed in
high Ca
2+ ringers (5 mM) after 15 minutes exposure to 4 mM
thapsigargin (Figure 5A). Similar to a methodology used by Luik et
al (2008)[27] the YFP signal of the periphery was compared to the
total signal to create a FP/FTotal ratio for the STIM1 fluorescence
for before and after exposure to thapsigargin. In cells expressing
mPC1, thapsigargin elicited no significant change in the STIM1
fluorescence ratio (p,0.298), suggesting that STIM1 did not
translocate after ER store depletion. In the control cells with no
mPC1 expression, thapsigargin induced a significant change in the
STIM1 ratio (p,0.001). Interestingly, the expression of PC1 also
limited the overall STIM1 fluorescence in the high Ca
2+ ringer
(p,0.001) in addition to the translocation of STIM1.
Figure 3. Polycystin-1 product CTF does not inhibit SOCE. (A) Western blot of PC1 cleavage product constructs P100 and CTF expressed in
Xenopus oocytes, immunoprecipitated with flag conjugated beads and probed with anti-CT antibody. (B) Averaged currents elicited by a 2120 mV
voltage step in H2O injected control oocytes (black trace, n=20) or from oocytes expressing CTF (red trace, n=14). (C) Mean current amplitudes at
the transient peak and steady state. 6SEM.
doi:10.1371/journal.pone.0012305.g003
SOCE Regulation by PC1
PLoS ONE | www.plosone.org 5 August 2010 | Volume 5 | Issue 8 | e12305P100 physically interacts with STIM1
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P100 and STIM1 could be co-precipitated using an anti-STIM1
antibody, and visualized with the anti-PC1 CT antibody (Figure 6A).
Consistent with the lack of SOCE inhibition, CTF was not pulled
down with the anti-STIM1 antibody (Figure 6A). CTF and P100
expression was confirmed by immunoprecipitating the same lysate with
Flag congregated beads then probing with the anti-PC1 CT antibody
(Figure 6A). STIM1 expression was also verified under each condition
(Figure 6B). The STIM1/P100 interaction was confirmed by
Figure 4. Polycystin-1 product P100 inhibits SOCE. (A) Averaged currents elicited by a 2120 mV voltage step in H2O injected control oocytes
(black trace, n=38) or from oocytes expressing P100 (red trace, n=18). (B) Mean current amplitudes at the transient peak and steady state. 6SEM;
(**p,0.01). (C) Averaged currents form P100 injected oocytes (red trace, n=11), and the same oocytes after three, 2 second, +60 mV pre-pulses
(‘‘induced’’ black trace, n=11). For comparison the calculated NFA sensitive Cl- current from supplemental Figure S2E (black dotted trace) and the
control currents from 4A (red dotted trace) are included. (D) Mean current amplitudes at the transient peak and steady state, including H2O control
data from 4A and calculated ICl- from Figure S2E. 6SEM; (***p,0.001)(*p,0.05). (E) Averaged currents in H2O injected control oocytes (black trace,
n=38), oocytes expressing the AESW construct (red trace, n=18), or oocytes expressing the P100 R4227X construct (blue trace, n=13). (F) Mean
current amplitudes at the transient peak and steady state; P100X is short for P100 R4227X. 6SEM; (**p,0.01).
doi:10.1371/journal.pone.0012305.g004
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visualized with the anti-STIM1 antibody (Figure 6C). The possible
functional interaction of P100 and STIM1 was assessed like full length
PC1 above. CHO cells were transfected with YFP-STIM1 and either
an empty plasmid or P100 and photographed in 5mM Ca
2+ ringers
and again 10 minutes after exposure to 8 mM thapsigargin (Figure 6E).
In CHO cells expressing YFP-Stim1 alone, ten minutes of thapsigargin
treatment altered the STIM1 localization from a diffuse ER pattern to
dramatic puncta around the periphery of the cell. However, the co-
expression of YFP-Stim1 and P100 presents a different localization
pattern, with very little of the puncta signal or YFP signal just beneath
the plasma membrane. The inhibition of STIM1 re-localization in the
presence of the P100 is not total, but does suggest that PC1 regulates
Ca
2+ entry through the generation of P100.
Discussion
In this study, we have discovered a previously unrecognized
endogenously expressed PC1 product of , 100 kDa, P100, in
various tissues including the kidney. Importantly, we also detected
P100 in cells expressing recombinant PC1 with a full-length PKD1
cDNA expression construct. Together, these data indicate that
P100 is most likely derived from proteolytic cleavage within the
third intracellular loop and is expected to contain the final 6
transmembrane domains and the C-terminal tail, a segment of
PC1 with significant sequence similarity to PC2. Interestingly,
P100 is not produced in Xenopus oocytes or in CHO cells
expressing only the CTF product, thus P100 cleavage may occur
uniquely in the context of full-length PC1. One possible
explanation for the differential cleavage of full length PC1 and
CTF is that they are distributed in different subcellular locations
with differing proteases. P100 is also present in Pkd1
V/V kidneys,
indicating that P100 cleavage does not require GPS cleavage.
Therefore, the full-length PC1 can act as a reservoir for generating
CTF/NTF and P100 in vivo. PKD1
V/V mice have severely cystic
kidneys at postnatal stages, but have no embryonic lethality in
contrast to PKD1 knock-out mice [16]. The generation of P100 in
Pkd1
V/V mice raises the possibility that P100 may help prevent
Figure 5. PC1 inhibits STIM1 translocation after ER Ca
2+ depletion. (A) MDCK cells stably transfected with either mouse PC1 (+mPC1) or an
empty vector (-mPC1) and transiently transfected with YFP-STIM1 imaged in 5 mM Ca
2+ ringers and again after 15 min in zero Ca
2+ with 4 mM
thapsigargin. (B) Translocation of the YFP-STIM1 was monitored as the ratio of peripheral YFP signal (FP) to the total YFP signal per cell (FTot). For
mPC1 expressing MDCK cells, n=4 coverslips, 12 cells; for control cells, n=4 coverslips, 47 cells. Scale bar in images is 20 mM. 6SEM; (***p,0.001).
doi:10.1371/journal.pone.0012305.g005
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PLoS ONE | www.plosone.org 7 August 2010 | Volume 5 | Issue 8 | e12305Figure 6. P100 physically interacts with STIM1. (A) CHO cells transiently transfected with STIM1 and either P100 or CTF construct;
immunoprecipitated with anti-STIM1 antibody, then probed with anti-CT;or immunoprecipitated with flag conjugated beads then probed with the
anti-CT antibody to verify transfection of PC1 products. * denotes endogenous STIM1 only. (B) STIM1 expression was verified by probing the same
lysate and immunoprecipitate used in A and B with anti-STIM1 antibody. Blots representative of at least 3 experiments. (C) To confirm the pull down
of P100 by STIM1, the reverse was attempted, pulling down STIM1 with P100. CHO cells were again transiently transfected with STIM1 and P100 or
STIM1 alone. The Flag tagged P100 was immunoprecipitated with flag conjugated beads then probed with anti-STIM1 antibody. The expression of
SOCE Regulation by PC1
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cystic expansion of the kidney and pancreas observed in PKD1
knockouts, and therefore may have an important function during
embryonic development.
Differential cleavage of full length PC1 and CTF could also be
due to specific localization of a regulatory protein. Bertuccio et al
(2009)[26] found that cleavage of PC1 into the CTT PC1 product
is directly dependent on the expression of PC2. We also looked
into the possible role of PC2 on P100 creation and found over
expression of PC2 increased the amount of PC1 cleavage
products, generally, but not any one specifically (Figure 2C). We
also found, unlike Bertuccio et al (2009)[26], that ER Ca
2+ levels
had a small effect on the amount of PC1 cleavage, again generally,
with no change in the CTF to P100 ratio. This could mean that
ER Ca
2+ levels or PC2 expression may not affect directly the P100
cleavage event, but more likely affect generally the stability of the
PC1 products. The nature of the PC1 cleavage responsible for
generating P100 is currently unknown.
We have also found that PC1 expression, and specifically P100,
leads to an inhibition SOCE, an occurrence hereto unreported.
PC1 mediated inhibition of SOCE could lower ER Ca
2+ levels and
shorten/reduce cytosolic Ca
2+ transients [28], conditions known to
increase resistance to apoptosis and proliferation [10]. Previously,
SOCE inhibition has been directly linked to regulation of
apoptosis and proliferation via multiple pathways [29–31]. In
addition, many physiological ligands (e.g. ATP) act through the
PLC/IP3 pathway to increase the release of Ca
2+ form ER stores
and raise cytosolic Ca
2+. PC1, therefore, may attenuate the extent
of net intracellular Ca
2+ increases upon exposure to physiological
stimuli. Li et al (2009)[20] showed that an ER localized PC1
fragment, QIF38 (identical to our P100), directly associates with
IP3R to inhibit Ca
2+ release from ER stores upon IP3 stimulation,
an action that results in attenuated responses to exogenous ATP
application in MDCK cells [20]. These findings taken with our
own form a consistent picture of ER localized PC1 products acting
to limit transient Ca
2+ responses to physiological stimuli.
Interestingly, a number of studies using the C-terminal tail of
PC1 over expressed as a fusion protein have found the inverse; the
expression of C-terminal tail leads to increases in intracellular
Ca
2+ and SOCE [32,33]. However, in light of recent findings by
Basavanna et al (2007)[34] who showed that the over expression of
a PC1 C-terminus fusion protein acted as a dominant negative,
these seemingly contrary findings may in fact be supportive of our
hypothesis that PC1 expression leads to inhibition of the SOCE.
Can PC1’s regulation of SOCE play a role in ADPKD? We
found that a disease causing mutation in PC1, R4227X, does not
inhibit SOC currents when expressed in Xenopus oocytes. These
results suggest dysfunctional SOCE regulation (Figure 7) may
disrupt normal Ca
2+ homeostasis and therefore play a significant
role in ADPKD. The same R4227X mutation also disrupts PC1/
PC2 interactions [6] suggesting a role for PC2 in SOCE regulation.
Finally, we have demonstrated that expression of PC1 and P100
interferes with STIM1 translocation upon ER Ca
2+ depletion.
Normally, STIM1 in the absence of ER Ca
2+ oligomerizes [35,36]
then secondarily translocates to form puncta at the ER-PM
junction [35,37,38]. Oligomerization is dependent on the
interactions of the EF-SAM regions located in the ER lumen
portion of STIM1 [36], but translocation and puncta formation
are dependent on the cytosolic polybasic [37,38] and coil-coiled
domains [35,39]. Therefore, considering the C-terminal coil-
coiled domain of P100, it seems most likely P100 interferes with
the corresponding cytosolic domains of STIM1 which would
predominately alter STIM1 translocation and puncta formation at
the ER-PM junction (Figure 7). Further work on the involvement
of the STIM1 coil-coiled domains in oligomerization would be
necessary to confirm this prediction. Previously, the only reported
physiological instances of either SOCE, CRAC, or specifically
STIM1 suppression was during cell division, regulated by the
phosphorylation of STIM1 [40]. Our data support an additional
avenue of SOCE regulation, independent of cell division, a direct
inhibition of STIM1 translocation by another protein, PC1.
Although STIM1 has been shown to interact with a number of
proteins (Orai and TRP channels), the PC1 interactions described
here are among the first to describe a protein interaction that
inhibits STIM1 function.
Methods
Detailed methods can be found in the Supporting Information
section (Methods S1).
STIM1 was verified by probing the lysate directly with the anti-STIM1 antibody. (D) The expression of P100 was confirmed by probing the lysate and
the immunoprecipitate with anti-Flag. Blots representative of at least 3 experiments. (E) CHO cells transfected with YFP-STIM1 and P100 (right) or the
empty plasmid (left) and imaged first in a 5 mM Ca
2+ bath solution (top) then again after a 10 min incubation in a zero Ca
2+ bath with 8 mM
thapsigargin (bottom). P100 retards the peripheral YFP puncta formation.
doi:10.1371/journal.pone.0012305.g006
Figure 7. Model of P100 STIM1 interaction in the ER. (A) When ER Ca
2+ stores are full STIM1 has Ca
2+ bound and is evenly distributed
throughout the endoplasmic reticulum (ER) membrane. Upon ER store depletion, STIM1 may oligomerize but does not translocate to areas of the ER
near the plasma membrane (PM) when the polycystin-1 cleavage product P100 is present, inhibiting the activation of store operated Ca
2+ (SOC)
currents.
doi:10.1371/journal.pone.0012305.g007
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Whole cell voltage clamp recordings from the Xenopus oocytes
were performed at room temperature in standard ND-96 ringers
solution (in mM: 96 NaCl, 2 KCl, 1 MgCl2, 1.8 CaCl2, 5 hepes,
pH 7.5). To increase the conductance of endogenous SOC
currents, oocytes were pretreated with 4 mM thapsigargin
(Sigma-Aldrich, USA) for up to 2 hours in the zero Ca
2+ bath
solution; generally, recordings were begun 3 minutes after the
Ca
2+ containing ND-96 bath solution was re-introduced to the
oocytes. A holding potential of 240 mV was used on all oocytes.
Mammalian Cells and culturing conditions
Stably transfected Madin-Darby canine kidney (MDCK) cells
were a generous gift from Gregory G. Germino (NIDDK,
Bethesda, MD USA) and cultured with selection agents hygro-
mycin (100 mg/ml) and blasticidin (5 mg/ml).
Plasmids and constructs
The human P100, the P100 R4227X, and the human PC1
fragment AESW constructs were also described previously under
the names QIF38, R4227X, and AESW respectively [20]. The
human STIM1 constructs, A151 and YFP-STIM1 were a generous
gift from Guang Huang and Paul Worley (Johns Hopkins School of
Medicine, Department of Neuroscience, Baltimore, MD USA).
Fura 2 Ca
2+ imaging and STIM1 images
CHO cells were rinsed with non-supplemented media then
loaded with fura 2 (Invitrogen, USA). The cover slips were then
bathed in a zero Ca
2+ solution (in mM: 120 NaCl, 4.5 KCl, 1
EGTA, 2 MgCl2, 10 hepes, pH 7.4). Images were acquired once
every 5 seconds using IPLab Software (BD Biosciences, USA).
Thapsigargin (Sigma, USA, 4 mM) was used to deplete ER stores
and high Ca
2+ ringers (in mM: 120 NaCl, 4.5 KCl, 2 MgCl2,1 0
hepes, and 3–5 CaCl2, pH 7.4) was secondarily applied to observe
the store depletion activated Ca
2+ entry. For STIM1 translocation
assays, CHO cells expressing either YFP-STIM1 alone or with the
CTF-100 construct began in high Ca
2+ ringer then the bath was
replaced with the zero Ca
2+ ringer and 8 mM thapsigargin. For
live images of STIM1 translocation in MDCK cells, MDCK cells
stably transfected with either murine PC1 or the blank vector in
addition to the YFP-STIM1 construct. 4 mM thapsigargin was
used for store depletion. STIM1 translocation analysis was done
as described by Luik et al (2008)[27]. All reported means are
6 standard error of the mean (SEM).
Supporting Information
Methods S1 Detailed methods.
Found at: doi:10.1371/journal.pone.0012305.s001 (0.03 MB
DOC)
Figure S1 Biochemical characterizationofPC-1 product,P100 in
Myc-tagged knock in mouse model. (A) PKD1 alleles and schematic
diagram oftheircorrespondingpolycystin-1proteins.PKD1
Mycand
PKD1
DCMyc are 5xMyc-tagged Pkd1 knock-in alleles that produce
fully functional PC1 protein. The domains in polycystin-1 are
shown. The Pkd1
DCmyc allele produces 5xMyc-tagged truncated
polycystin-1 protein with deletion of C-terminal 257 amino acids
[21]. (B) Western blot for heterozygous Pkd1
myc/+ and Pkd1
DCmyc/+
and their wild-type littermate embryo (E17) using anti-Myc
antibody after immunoprecipitation. The truncated CTF
DCmyc/+
and P100
DCmyc/+ are detected in the Pkd1
DCmyc/+ embryo.
Found at: doi:10.1371/journal.pone.0012305.s002 (1.73 MB EPS)
Figure S2 SOC and CaCC currents in Xenopus laevis oocytes.
(A) Currents elicited from a representative H2O injected control
Xenopus laevis oocytes 3–5 days after injection in a ND96 bath
solution subjected to a +20mV step protocol from 2100 mV to
+60 mV from an initial holding potential of 240 mV. (B)
Currents elicited from a representative H2O injected control
oocyte pretreated with 4 mMt h a p s i g a r g i ni naz e r oC a
2+ ND96.
(C) Summary steady state current/voltage relation from H2O
injected control oocytes with (blue circles, n=21) or without (red
triangles, n=13) thapsigargin/zero Ca
2+ ND96 pretreatment.
6SEM; (**p,0.01). (D) Averaged currents in H2O inject control
oocytes elicited by a 10 second voltage step to 2120 mV from a
240 mV holding potential. For each cell (n=4) currents were
first recorded in zero Ca
2+ ND96 (blue trace), then in the normal
ND96 (1.8 mM Ca
2+)(black trace) and finally in ND96 with
100 mML a
3+ (red trace). Inset: mean current amplitudes at the
transient peak (1.5 sec from beginning of record) and at the
steady state (10 sec from beginning of record). 6SEM;
(**p,0.01)(*p,0.05). (E) Averaged currents in H2O inject
control oocytes elicited by a 10 second voltage step to
2120 mV from a 240 mV holding potential. For each cell
(n=10) currents were recorded before (black trace) and after (red
trace) replacing the bath with a low Cl- bath containing 100 mM
Niflumic acid (NFA). Currents were recorded from a subset of
cells (n=4) further treated with 100 mML a
3+ (blue trace).
Subtraction of currents before and after treatment with NFA
indicates the waveform of the NFA sensitive, probable Cl-
currents (black dotted black trace). Inset: mean current
amplitudes at the transient peak and steady state. 6SEM;
(**p,0.01)(*p,0.05). (F) Measurements of transient peak current
reversal potentials. Current/voltage relation of tail current
amplitudes after initial 2120 mV step in normal ND96 bath
(black squares, n=9), low Cl-/100 mM NFA bath (red circles,
n=9), or low Cl-/100 mMN F A / 1 0 0 mML a
3+ bath (blue
triangles, n=4). Inset: representative tail current measurements
using reversal potential paradigm.
Found at: doi:10.1371/journal.pone.0012305.s003 (3.58 MB
EPS)
Figure S3 Expression of Polycystin-1 cleavage products have
differing effects on store operated Ca
2+ influx. Fura 2- AM
measurements in CHO cells expressing PC1 cleavage products.
Recordings began after cells reached steady state in a zero Ca
2+,
4 mM thapsigargin ringers. The bath was then replaced with a
high Ca
2+ bath and Ca
2+ influx through SOC channels is
measured. (A) CHO cells transiently transfected with CTF (Red
trace, n=4 coverslips, 36 cells) or empty plasmid control (Black
trace, n=7 coverslips, 58 cells). (B) CHO cells transiently
transfected with AESW (Red trace, n=6 coverslips, 24 cells) or
empty plasmid control (Black trace, n=7 coverslips, 34 cells).
6SEM; (*p,0.05).
Found at: doi:10.1371/journal.pone.0012305.s004 (0.82 MB
EPS)
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